Archidply IPO vs Bafna Pharmaceuticals IPO

Comparision between Archidply IPO and Bafna Pharmaceuticals IPO.

IPO Details

Archidply IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Bafna Pharmaceuticals IPO is a Mainline Fixed Price Issue proposed to list at BSE.

	Archidply IPO	Bafna Pharmaceuticals IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Fixed Price Issue
Listing At	BSE, NSE	BSE
Lead Managers	Motilal Oswal Investment Advisors Limited	Keynote Financial Services Ltd Ashika Capital Ltd
Registrar	Kfin Technologies Limited	Cameo Corporate Services Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Archidply IPO is up to ₹48.96 Cr whereas the issue size of the Bafna Pharmaceuticals IPO is up to ₹25.60 Cr. The final issue price of Archidply IPO is ₹74.00 per share and of Bafna Pharmaceuticals IPO is ₹40.00 per share.

	Archidply IPO	Bafna Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹70.00 per share
Issue Price (Upper)	₹80.00 per share
Issue Price (Final)	₹74.00 per share	₹40.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	75 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	66,15,720 shares	64,00,000 shares
Issue Size Total (Amount)	up to ₹48.96 Cr	up to ₹25.60 Cr

IPO Timetable

Archidply IPO opens on Jun 11, 2007, while Bafna Pharmaceuticals IPO opens on May 27, 2008. The closing date of Archidply IPO and Bafna Pharmaceuticals IPO is Jun 17, 2008, and May 30, 2008, respectively.

	Archidply IPO	Bafna Pharmaceuticals IPO
Anchor Bid Date
Issue Open	Jun 11, 2007	May 27, 2008
Issue Close	Jun 17, 2008	May 30, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Archidply IPO P/E ratio is , as compared to Bafna Pharmaceuticals IPO P/E ratio of .

Archidply IPO

Bafna Pharmaceuticals IPO

Financial

Particulars	For the year/period ended (Rs. in lacs)
	30-Sep-07	31-Mar-07
Total Income	6,602.63	10,062.88
Profit After Tax (PAT)	680.85	524.85

Particulars	For the year/period ended (Rs. in lacs)
	30-Jun-07	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04
Total Income	432.02	3861.96	2136.47	2662.65	1521.33
Profit After Tax (PAT)	49.70	104.23	92.27	89.81	44.51

Promoter Shareholding (Pre-Issue)

97.68%

71.07%

Promoter Shareholding (Post-Issue)

68.31%

42.6%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

21.87%%

10.65%%

Shares Offered

In the Archidply IPO retail investors (RII) are offered while in Bafna Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Archidply IPO and in Bafna Pharmaceuticals IPO.

	Archidply IPO	Bafna Pharmaceuticals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Archidply IPO subscribed 1.52x in total, whereas Bafna Pharmaceuticals IPO subscribed .

	Archidply IPO	Bafna Pharmaceuticals IPO
QIB (times)	0.20x
NII (times)	2.36x
Big NII (times)
Small NII (times)
RII (times)	3.04x
Employee (times)
Other (times)
Total (times)	1.52x

Compare with others

Archidply IPO	Bafna Pharmaceuticals IPO
Vishal Information IPO	Archidply IPO
Birla Cotsyn IPO	First Winner IPO
KSK Energy IPO	Sejal IPO
Somi Conveyor IPO	Avon Weighing IPO
Lotus Eye Care IPO	MCX IPO
First Winner IPO	Niraj Cement Structurals IPO
Sejal IPO	Anu Laboratories IPO
Avon Weighing IPO	Gokul Refoils IPO
MCX IPO	Aishwarya Telecom IPO
Bafna Pharmaceuticals IPO	Titagarh Wagons IPO

Comments

Add a public comment...